Watch CBS News

New Alzheimer's drug receives accelerated FDA approval

The medication, which is called Lecanemab, was designed to reduce amyloid beta plaque in the brain that's linked to the disease.
View CBS News In
CBS News App Open
Chrome Safari Continue
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.